

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.
You can purchase shares of State Street SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
There are no as such competitors for State Street SPDR S&P Pharmaceuticals ETF.
There is no analysis for State Street SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
The stock price for State Street SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $ last updated .
There are no upcoming dividends for State Street SPDR S&P Pharmaceuticals ETF.
State Street SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
There is no upcoming split for State Street SPDR S&P Pharmaceuticals ETF.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the...